Abstract
Despite significant improvements in the prognosis of childhood acute lymphoblastic leukaemia (ALL), the risk of anthracycline-induced cardiovascular disease remains a major concern. This study was designed to investigate the role of the myocardial performance index (MPI) and serum concentrations of biomarkers (cTnT and NT-pro-BNP) in the early detection of subclinical anthracycline-induced functional alterations in children with ALL.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 927-933 |
Numero di pagine | 7 |
Rivista | International Journal of Clinical Oncology |
Volume | 18 |
Numero di pubblicazione | 5 |
DOI | |
Stato di pubblicazione | Pubblicato - 2013 |
All Science Journal Classification (ASJC) codes
- Chirurgia
- Ematologia
- Oncologia
Keywords
- Myocardial performance index
- biochemical markers
- cardiotoxicity
- doxorubicin